Bladder cancer is associated with a high risk of recurrence and progression to muscle invasive disease. Due to these risks urologists appropriately recommend cystoscopic surveillance for these patients. However, standard office white light surveillance cystoscopy (WLC) is not without its nuances and is far from a perfect surveillance modality.
